GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.

GLP-1 medications mimic a natural hormone that controls appetite, blood sugar, and digestion. Monthly costs range from $199 to over $1,300, depending on the specific medication and insurance coverage.

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsBrian Lian - President, CEO ...

Takeda Pharmaceutical Company Limited ( TAK) TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM EST ...

Cone snails deploy sophisticated venom cocktails to paralyse prey. Anthony King talks to the researchers harnessing these ...

A newcomer will soon join the hallowed halls of the Oscars' best supporting actor category. Before the March 15 awards, we ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

According to Sadaf Javed, Manager of Forecasting and Analytics at DelveInsight, the pharmaceutical industry is becoming more interested in targeted radiation therapy as a novel, promising cancer ...

The market for radioligand therapies is expected to grow significantly in the coming years. This is due to the increasing number of patients who are being diagnosed with cancer, the growing ...

From the original show and Fear, to Dead City and Daryl Dixon ...

The table below is a review of notable updates that occurred in February 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.